NCT05088798View on ClinicalTrials.gov

Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 10, 2020

Primary Completion Date

January 1, 2030

Study Completion Date

January 1, 2030

Conditions
Hyperinsulinism
Interventions
DRUG

18F-Fluoro Dopa PET/MRI Imaging

The purpose of this research study is to provide access to an imaging study of the pancreas that uses 6-\[18F\]-Fluoro-L-3,4,-dihydroxyphenylalanine (18F-DOPA)positron emission tomography (PET) and assess the accuracy of this 18F-DOPA-PET/MRI test on distinguishing what part of the pancreas is affected in patients with Hyperinsulinism.

Trial Locations (1)

63110

RECRUITING

Washington University, St Louis

All Listed Sponsors
collaborator

St. Louis Children's Hospital

OTHER

lead

Washington University School of Medicine

OTHER